True to its name, Signature Select Canadian Fund (Trades, Portfolio) dealt in Canadian companies in the third quarter – although its portfolio was dotted here and there with investments elsewhere, most notably in the U.S. and the United Kingdom.
For the most part, its investment activity was in Canada.
Signature Select’s most significant third-quarter transaction was the divestiture of its 634,500-share stake in SPDR Gold Trust (ETF) [GLD] for an average price of $107.82 per share. The transaction had a -5.48% impact on Signature Select’s portfolio.
John Paulson (Trades, Portfolio), First Eagle Investment (Trades, Portfolio), John Hussman (Trades, Portfolio), Louis Moore Bacon (Trades, Portfolio) and Richard Snow (Trades, Portfolio) have shares of SPDR Gold Trust in their portfolios.
SPDR Gold Trust sold for $103.11 per share Saturday.
Signature Select sold its 169,900-share stake in International Paper Co. (IP, Financial), a Memphis, Tennessee-based pulp and paper company, for an average price of $44.83 per share. The deal had a -0.72% impact on Signature Select’s portfolio.
International Paper has a market cap of $15.81 billion and an enterprise value of $19.62 billion. It has a P/E of 18.0, a forward P/E of 9.7, a P/B of 3.6 and a P/S of 0.7. GuruFocus has given International Paper a Financial Strength rating of 6/10 and a Profitability and Growth rating of 5/10.
T Rowe Price Equity Income Fund (Trades, Portfolio), HOTCHKIS & WILEY, Richard Snow (Trades, Portfolio), Jim Simons (Trades, Portfolio), James Barrow (Trades, Portfolio), Pioneer Investments (Trades, Portfolio), Ray Dalio (Trades, Portfolio), Joel Greenblatt (Trades, Portfolio), Manning & Napier Advisors Inc., Mario Gabelli (Trades, Portfolio), Steven Cohen (Trades, Portfolio), Paul Tudor Jones (Trades, Portfolio) and David Dreman (Trades, Portfolio) have shares of International Paper in their portfolios.
On Saturday International Paper sold for $38.13 per share.
Signature Select increased its position in Toronto-Dominion Bank (TSX:TD, Financial), a Toronto-based financial services company, by nearly 27%. Signature Select bought 398,500 shares for an average price of C$53.57 (about $38.94 in U.S. currency) per share. The transaction had a 1.41% impact on Signature Select’s portfolio.
Toronto-Dominion Bank has a market cap of $98.98 billion and an enterprise value of $66.29 billion. It has a P/E of 12.8, a forward P/E of 11.0, a P/B of 1.6 and a P/S of 3.2. GuruFocus has given Toronto-Dominion Bank a Financial Strength rating of 6/10 and a Profitability and Growth rating of 7/10.
Mawer Canadian Equity Fund (Trades, Portfolio) and Leith Wheeler Canadian Equity (Trades, Portfolio) have shares of Toronto-Dominion Bank in their portfolios.
Toronto-Dominion Bank sold for C$53.3 (roughly $38.74 in American dollars) per share Friday.
Signature Select Canadian Fund (Trades, Portfolio) doubled its stake in Rogers Communications Inc. (TSX:RCI.B, Financial), a Toronto-based mass media and telecommunications company, acquiring 249,100 shares for an average price of C$43.93 (approximately $31.93 in U.S. money) per share. The deal had a 0.78% impact on Signature Select’s portfolio.
Rogers Communications has a market cap of $25.05 billion and an enterprise value of $42.4 billion. It has a P/E of 18.4, a forward P/E of 16.1, a P/B of 4.4 and a P/S of 1.9. GuruFocus has given Rogers Communications a Financial Strength rating of 6/10 and a Profitability and Growth rating of 6/10.
Mawer Canadian Equity Fund (Trades, Portfolio) has shares of Rogers Communications in its portfolio.
On Friday Rogers Communications sold for C$48.66 (about $35.37 in American currency) per share.
Signature Select quadrupled its stake in BCE Inc. (TSX:BCE, Financial), a Montreal-based telecommunications and mass media company, with the purchase of 189,600 shares for an average price of C$53.84 (roughly $39.13 in U.S. money) per share. The transaction had a 0.7% impact on Signature Select’s portfolio.
BCE has a market cap of $45.82 billion and an enterprise value of $70.36 billion. It has a P/E of 17.7, a forward P/E of 15.2, a P/B of 3.8 and a P/S of 2.1. GuruFocus has given BCE a Financial Strength rating of 7/10 and a Profitability and Growth rating of 8/10.
BCE sold for C$53.99 (approximately $39.24 in American dollars) per share Friday.
Signature Select invested in a 258,600-share stake in Bristol-Myers Squibb Company (BMY, Financial), a New York-based pharmaceutical company, for an average price of $63.44 per share. The transaction had a 1.38% impact on Signature Select’s portfolio.
Bristol-Myers Squibb has a market cap of $112.81 billion and an enterprise value of $114.86 billion. It has a P/E of 63.9, a forward P/E of 30.2, a P/B of 7.5 and a P/S of 6.9. GuruFocus has given Bristol-Myers Squibb a Financial Strength rating of 8/10 and a Profitability and Growth rating of 5/10.
Vanguard Health Care Fund (Trades, Portfolio), T Rowe Price Equity Income Fund (Trades, Portfolio), Steven Cohen (Trades, Portfolio), Mario Gabelli (Trades, Portfolio), RS Investment Management (Trades, Portfolio), John Burbank (Trades, Portfolio), Mairs and Power (Trades, Portfolio), Ronald Muhlenkamp (Trades, Portfolio), Pioneer Investments (Trades, Portfolio), Dodge & Cox, Ken Fisher (Trades, Portfolio), Murray Stahl (Trades, Portfolio), Kahn Brothers (Trades, Portfolio), Joel Greenblatt (Trades, Portfolio), Ray Dalio (Trades, Portfolio), Paul Tudor Jones (Trades, Portfolio), First Eagle Investment (Trades, Portfolio), Jeremy Grantham (Trades, Portfolio), Jeff Auxier (Trades, Portfolio), George Soros (Trades, Portfolio) and Ruane Cunniff (Trades, Portfolio) have shares of Bristol-Myers Squibb in their portfolios.
Bristol-Myers Squibb sold for $67.62 per share Saturday.
Signature Select bought a 192,600-share stake in AstraZeneca PLC (LSE:AZN, Financial), a London-based pharmaceutical company, for an average price of £42.4 (roughly $64.55 in U.S. dollars) per share. The deal had a 1.1% impact on Signature Select’s portfolio.
AstraZeneca has a market cap of $54.73 billion and an enterprise value of $58.9 billion. It has a P/E of 49.4, a forward P/E of 16.4, a P/B of 4.8 and a P/S of 3.4. GuruFocus has given AstraZeneca a Financial Strength rating of 6/10 and a Profitability and Growth rating of 5/10.
Vanguard Health Care Fund (Trades, Portfolio) has shares of AstraZeneca in its portfolio.
On Friday AstraZeneca sold for £43.3 (approximately $65.92 in American money) per share.
Signature Select purchased a 105,600-share stake in Canadian Tire Corp. (TSX:CTC.A), a Toronto-based retailer, for an average price of C$129.14 (about $93.86 in U.S. currency) per share. The transaction had a 0.86% impact on Signature Select’s portfolio.
Canadian Tire has a market cap of $9.04 billion and an enterprise value of $13.17 billion. It has a P/E of 25.7, a forward P/E of 24.0, a P/B of 3.2 and a P/S of 1.3. GuruFocus has given Canadian Tire a Financial Strength rating of 7/10 and a Profitability and Growth rating of 7/10.
Leith Wheeler Canadian Equity (Trades, Portfolio) has shares of Canadian Tire in its portfolio.
Canadian Tire sold for C$120.59 (roughly $87.65 in American dollars) per share Friday.
Signature Select acquired a 282,200-share stake in Gildan Activewear Inc. (TSX:GIL), a Montreal-based textile and clothing company, for an average price of C$40.58 (approximately $29.50 in U.S. money) per share. The deal had a 0.77% impact on Signature Select’s portfolio.
Gildan Activewear has a market cap of $9.79 billion and an enterprise value of $10.46 billion. It has a P/E of 35.0, a forward P/E of 16.1, a P/B of 3.5 and a P/S of 3.4. GuruFocus has given Gildan Activewear a Financial Strength rating of 9/10 and a Profitability and Growth rating of 8/10.
On Friday Gildan Activewear sold for C$40.25 (roughly $29.26 in American currency) per share.
To view the portfolios of more gurus, visit the List of Gurus page. Not a premium member of GuruFocus? Try it free for 7 days.
